Marshall Wace
BMY icon

Marshall Wace’s Bristol-Myers Squibb BMY Stock Holding History

Marshall Wace’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$5.39K – 3210
2025
Q4 		$5.39K Hold
100
– – ﹤0.01% 2877
2025
Q3 		$4.51K Buy
+100
New +$4.67K ﹤0.01% 2827
2023
Q3 		– Sell
-99,000
Closed -$6.33M – 2212
2023
Q2 		$6.33M Buy
+99,000
New +$6.64M 0.01% 924
2021
Q4 		– Sell
-300
Closed -$18K – 3870
2021
Q3 		$18K Buy
+300
New +$19.8K ﹤0.01% 2956

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace's BMY Position: Q2 2026 in Review

Marshall Wace reduced its Bristol-Myers Squibb (BMY) stake by 100% in Q2 2026, selling an estimated $211M and leaving 15,169 shares worth $874K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

Marshall Wace first reported a position in BMY in Q1 2014 and has held it in 42 quarters since. The position peaked at $585M in Q4 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Marshall Wace held 15,169 shares of Bristol-Myers Squibb worth $874K as of Q2 2026.
  • Marshall Wace sold 3,674,669 Bristol-Myers Squibb shares in Q2 2026, an estimated $211M.
  • Bristol-Myers Squibb made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2268 holding.
  • Marshall Wace first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 42 quarters since.
  • Marshall Wace's Bristol-Myers Squibb position peaked at $585M in Q4 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.